Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/ON4 stock hub

FRA/ON4 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/ON4is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.3B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/ON4

In the news

Latest news · FRA/ON4

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E16.6

P25 n/aP50 n/aP75 n/a

ROE8.5

P25 n/aP50 n/aP75 n/a

ROIC9.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/ON4 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

JPY

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	DE
Employees	4,287
Employees Change	434%
Employees Change Percent	11.26
Enterprise value	EUR 5.7B
Exchange	Frankfurt Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 6.3B
Price	EUR 13.38
Price currency	EUR
Rev Per Employee	656,256.7x
Sic	2834
Symbol	fra/ON4
Website	https://www.ono-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.02%
EV Earnings	15.04x
EV/EBIT	11.44x
EV/EBITDA	8.12x
EV/FCF	8.02x
EV/Sales	2.05x
FCF yield	11.28%
P/B ratio	1.35x
P/E ratio	16.62x
P/S ratio	2.25x
PE Ratio10 Y	20.58x
PE Ratio3 Y	12.58x
PE Ratio5 Y	14.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.88%
EBITDA Margin	25.2%
FCF margin	25.36%
Gross margin	72.52%
Gross Profit	EUR 2B
Gross Profit Growth	10.37%
Gross Profit Growth Q	27.76%
Gross Profit Growth3 Y	3.53%
Gross Profit Growth5 Y	10.83%
Net Income	EUR 380.5M
Net Income Growth	39.4%
Net Income Growth3 Y	-14.78%
Net Income Growth5 Y	-1.55%
Pretax Margin	17.96%
Profit Margin	13.53%
Profit Per Employee	EUR 88,768
ROA	5.31
Roa5y	8.25
ROCE	9.78
ROE	8.5
Roe5y	11.96
ROIC	9.15
Roic5y	13.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	42.91%
Cagr3y	-6.18%
Div CAGR3	-4.52%
EPS Growth	39.47
EPS Growth3 Y	-13.69
EPS Growth5 Y	-0.36
FCF Growth	69.8%
FCF Growth Q	30.69%
FCF Growth3 Y	-5.35%
FCF Growth5 Y	14.33%
OCF Growth	65.93%
OCF Growth Q	28.69%
OCF Growth10 Y	26.69%
OCF Growth3 Y	-5.01%
OCF Growth5 Y	13.09%
Revenue Growth	5.94x
Revenue Growth Q	5.73x
Revenue Growth3 Y	4.87x
Revenue Growth5 Y	10.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.48
Assets	EUR 6B
Cash	EUR 1.3B
Current Assets	EUR 2.5B
Current Liabilities	EUR 885.7M
Debt	EUR 659.6M
Debt EBITDA	EUR 0.93
Debt Equity	EUR 0.14
Debt FCF	EUR 0.92
Equity	EUR 4.7B
Interest Coverage	26.06
Liabilities	EUR 1.4B
Long Term Assets	EUR 3.5B
Long Term Liabilities	EUR 477.2M
Net Cash	EUR 633.7M
Net Cash By Market Cap	EUR 10.02
Net Cash Growth	86.27%
Net Debt EBITDA	EUR -0.89
Net Debt Equity	EUR -0.14
Net Debt FCF	EUR -0.89
Tangible Book Value	EUR 2.6B
Tangible Book Value Per Share	EUR 5.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.86
Inventory Turnover	2.14
Net Working Capital	EUR 578.3M
Quick ratio	2.34
Working Capital	EUR 1.7B
Working Capital Turnover	EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.07%
Dividend Growth	-9.52%
Dividend Growth Years	0%
Dividend per share	EUR 0.45
Dividend Years	6
Dividend Yield	3.45%
Ex Div Date	2026-03-30
Last Dividend	EUR 0.22
Payout Frequency	Semi-Annual
Payout Ratio	53.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	42.88%
200-day SMA	11.45
3Y total return	-17.42%
50-day SMA	12.98
50-day SMA vs 200-day SMA	50over200
All Time High	27.6
All Time High Change	-51.52%
All Time High Date	2022-07-14
All Time Low	8.95
All Time Low Change	49.5%
All Time Low Date	2025-07-08
ATR	0.26
Ch YTD	16.35
High	13.52
High52	14.5
High52 Date	2026-02-27
High52ch	-7.72%
Low	13.38
Low52	8.95
Low52 Date	2025-07-08
Low52ch	49.5%
Ma50ch	3.09%
Price vs 200-day SMA	16.84%
RSI	60.4
RSI Monthly	53.97
RSI Weekly	59.61
Sharpe ratio	1.37x
Sortino ratio	2.32
Total Return	3.38%
Tr YTD	18.28
Tr1m	-1.62%
Tr1w	7.26%
Tr3m	3.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 503.1M
Operating Income Growth	49.27
Operating Income Growth3 Y	-14.97
Operating Income Growth5 Y	-1.35
Operating margin	17.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	453,493,556%
Net Borrowing	-133,208,996.5
Shares Insiders	0.06%
Shares Institutions	41.51%
Shares Qo Q	0.11%
Shares Yo Y	0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 713.4M
Average Volume	0x
Bv Per Share	9.88
CAPEX	EUR -32.9M
Ch1m	-1.62
Ch1w	7.26
Ch1y	37.23
Ch3m	1.36
Ch3y	-26.48
Ch6m	26.23
Change	3.4%
Change From Open	-0.07
Close	12.94
Days Gap	3.48
Depreciation Amortization	204,335,705
Earnings Date	2026-05-08
EBIT	EUR 503.1M
EBITDA	EUR 709M
EPS	EUR 0.81
F Score	6
FCF	EUR 713.4M
FCF EV Yield	12.46x
Financing CF	-357,234,516
Fiscal Year End	March
Founded	1,717
Goodwill	122,616,578.2
Graham Number	13.38464
Graham Upside	0.03
Income Tax	EUR 124.1M
Investing CF	-217,418,164
Is Primary Listing	0
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Lynch Fair Value	EUR 4.03
Lynch Upside	-69.91
Ma150	12.04
Ma150ch	11.13%
Ma20	12.6
Ma20ch	6.22%
Net CF	177,163,622
Next Earnings Date	2026-07-31
Open	13.39
P FCF Ratio	8.86
P OCF Ratio	8.47
Payment Date	2026-06-22
Position In Range	0
Ppne	548,938,410.3
Price Date	2026-05-08
Price EBITDA	EUR 8.92
Ptbv Ratio	2.44
Relative Volume	7.38x
Revenue	2,813,372,493x
Tax By Revenue	4.41x
Tax Rate	24.55%
Tr6m	28.32%
Volume	0
Z Score	4.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/ON4 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$0.45 annual per share

Payout ratio

+53.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+3.4%

Next ex-dividend date: 2026-03-30

Performance

FRA/ON4 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/ON4?

Insider, institutional, and short-interest positioning.

Institutional ownership

+41.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

FRA/ON4 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.4

Neutral momentum band

Price vs 200-day MA

+16.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/ON4

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/ON4 stock rating?

fra/ON4 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/ON4 analysis?

The full report lives at /stocks/fra/ON4/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/ON4?

The latest report frames fra/ON4 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/ON4 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.